How to appeal a UnitedHealthcare gerd & severe reflux denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

UnitedHealthcare-specific note: UHC's parent UnitedHealth Group owns Optum (PBM Optum Rx) and Surest. Surest plans have different cost-sharing rules. State complaints flow to state insurance department + DOL/EBSA for self-funded.

What UnitedHealthcare's policy requires for gerd & severe reflux

Cited policy: OptumRx Voquezna (Vonoprazan) Prior Authorization

Documented failure / intolerance of >=2 generic PPIs at optimized BID dosing for >=8 weeks. EGD-confirmed erosive esophagitis (LA A-D) for healing indication, OR symptom-based per Jul 2024 non-erosive label expansion.

How UnitedHealthcare denies gerd & severe reflux — and how to counter it

Where UnitedHealthcare pushes back: 1) Try esomeprazole first; 2) Insufficient PPI trial; 3) LA grade not documented.

Counter-arguments that hold up: PHALCON-EE Gastroenterology 2023 — non-inferiority + superiority for LA-C/D. Voquezna FDA Nov 1, 2023 (NDA 215151). PCAB pharmacology = faster sustained pH >4, no CYP2C19 dependence. Document CYP2C19 rapid/ultrarapid metabolizer status, LA Grade C/D, or concomitant clopidogrel/methotrexate for omeprazole interaction.

What UnitedHealthcare typically denies for gerd & severe reflux

Across UnitedHealthcare's commercial and Medicare books, denials cluster around a small number of patterns. For gerd & severe reflux, expect:

• GLP-1 weight-loss exclusion
• Out-of-network reduction citing UCR
• Step therapy on biologics
• Prior auth denied for advanced imaging
• Quantity limits on specialty drugs

Treatments most often denied in this category

These are the gerd & severe reflux treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Generic PPI
• Branded PPI
• Voquezna (vonoprazan)
• H2 blocker
• Prokinetic
• Sucralfate

How to submit the appeal to UnitedHealthcare

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document UnitedHealthcare cited in the denial.
3. File the appeal through UnitedHealthcare's portal (members: https://www.myuhc.com ; providers: https://www.uhcprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See UnitedHealthcare's prior-authorization criteria by drug: UnitedHealthcare PA criteria on ApprovalHelp.